SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-058784
Filing Date
2018-11-09
Accepted
2018-11-09 16:34:21
Documents
86
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv506444_10q.htm 10-Q 757951
2 EXHIBIT 31.1 tv506444_ex31-1.htm EX-31.1 10038
3 EXHIBIT 31.2 tv506444_ex31-2.htm EX-31.2 9952
4 EXHIBIT 32.1 tv506444_ex32-1.htm EX-32.1 4154
5 EXHIBIT 32.2 tv506444_ex32-2.htm EX-32.2 4106
  Complete submission text file 0001144204-18-058784.txt   8102766

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eltp-20180930.xml EX-101.INS 2479838
7 XBRL TAXONOMY EXTENSION SCHEMA eltp-20180930.xsd EX-101.SCH 59135
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eltp-20180930_cal.xml EX-101.CAL 39103
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eltp-20180930_def.xml EX-101.DEF 359370
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltp-20180930_lab.xml EX-101.LAB 383722
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltp-20180930_pre.xml EX-101.PRE 413585
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 181173558
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1